All Stories

  1. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Article • The Lancet Child & Adolescent Health, February 2025, Elsevier

    Dr. Bakyt Bolotbekovich Myrzaliev, Lee Fairlie

  2. New Tuberculosis Drugs and the Role of Pharmacovigilance: Issues in Resource-Limited Countries

    Article • January 2025, Springer Science + Business Media

    Dr. Bakyt Bolotbekovich Myrzaliev

  3. Bedaquiline Pretomanid and Linezolid for Drug-Resistant Tuberculosis in Kyrgyzstan

    Article • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, August 2024, Elsevier

    Dr. Bakyt Bolotbekovich Myrzaliev

  4. A Case of Tuberculous Meningitis in a Pregnant Woman with Miliary Pulmonary Tuberculosis: Challenges in Diagnosis and Management

    Article • JOURNAL OF COMMUNICABLE DISEASES, June 2024, Advanced Research Publications, AS Research and Learning Solutions

    Dr. Bakyt Bolotbekovich Myrzaliev

  5. Кургак учукту дарылоонун жаңы этабы: Кургак учук менен күрөшүүдө инновациялык ыкмалар. “THE UNION” конференциясынын материалдары, 2023

    Article • Scientific and practical journal Healthcare of Kyrgyzstan, February 2024, Healthcare of Kyrgyzstan

    Dr. Bakyt Bolotbekovich Myrzaliev

  6. Бишкек шаарында жана Чүй облусунда IGRA тестин колдонуу менен жеке менчик саламаттык сактоо уюмдарында кургак учук инфекциясын жана активдүү кургак учукту аныктоо.

    Article • Scientific and practical journal Healthcare of Kyrgyzstan, February 2024, Healthcare of Kyrgyzstan

    Dr. Bakyt Bolotbekovich Myrzaliev

  7. Study on digital health and joint COVID-TB care to restore TB services in 4 high-burden countries.

    Article • PLOS One, November 2023, PLOS

    Dr. Bakyt Bolotbekovich Myrzaliev

  8. QuantiFERON-TB Gold plus testing for the detection of LTBI among health care workers in major TB hospitals of the Northern Kyrgyz Republic

    Article • BMC Infectious Diseases, February 2022, Springer Science + Business Media

    Dr. Bakyt Bolotbekovich Myrzaliev

  9. Prevalence of various strains of the causative agent of tuberculosis in tuberculosis patients in the Kyrgyz Republic

    Article • Scientific and practical journal Healthcare of Kyrgyzstan, January 2022, Healthcare of Kyrgyzstan

    Dr. Bakyt Bolotbekovich Myrzaliev

  10. Introduction of BPaL for the treatment of drug resistant tuberculosis in the Kyrgyz Republic

    Article • Scientific and practical journal Healthcare of Kyrgyzstan, January 2022, Healthcare of Kyrgyzstan

    Dr. Bakyt Bolotbekovich Myrzaliev

  11. Stakeholder readiness to adopt the new BPaL regimen for treating XDR-TB patients

    Article • BMC Public Health, July 2021, Springer Science + Business Media

    Dr. Bakyt Bolotbekovich Myrzaliev

  12. Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus

    Article • BMC Infectious Diseases, October 2020, Springer Science + Business Media

    Dr. Bakyt Bolotbekovich Myrzaliev

  13. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    Dr. Bakyt Bolotbekovich Myrzaliev